Sign In
Buy CWBR
$0.410
+0 (+0%)
At Close: Apr 22, 2025
CohBar, Inc. 2020 Q2 - Results - Earnings Call Presentation
04:16pm, Sunday, 16'th Aug 2020
The following slide deck was published by CohBar, Inc. in conjunction with their 2020 Q2 earnings call..
CohBar, Inc. (CWBR) CEO Steve Engle on Q2 2020 Results - Earnings Call Transcript
09:38pm, Thursday, 13'th Aug 2020
CohBar, Inc. (NASDAQ:CWBR) Q2 2020 Earnings Conference Call August 13, 2020, 05:00 PM ET Company Participants Jordyn Tarazi - Director of IR Steve Engle - CEO Ken Cundy - Chief Scientific Officer Jeff
CohBar Reports Second Quarter 2020 Financial Results and Provides Business Update
08:03pm, Thursday, 13'th Aug 2020
New positive preliminary preclinical results in ARDS model Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR)
CohBar Presents New Antifibrotic Data at the American Thoracic Society’s Virtual 2020 Conference
01:00pm, Wednesday, 05'th Aug 2020
In vivo data demonstrates antifibrotic effects of multiple novel peptide analogs in preclinical models of idiopathic pulmonary fibrosis (IPF)MENLO PARK, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- CohBa
CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020
01:00pm, Thursday, 30'th Jul 2020
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochon
How To Time The Market Without The Emotional Baggage
07:26pm, Monday, 20'th Jul 2020
Timing stock market moves is a taboo subject, and rightly so. Most of the time, investors are wise to avoid big moves into and out of stocks.
Why does the optimal policy exist?
10:42pm, Saturday, 18'th Jul 2020
A proof of the existence of the optimal policy for finite MDPs
CohBar Resumes CB4211 Phase 1b Clinical Trial
01:00pm, Tuesday, 07'th Jul 2020
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that it has resumed the Ph
CohBar to Present at Sachs Novel Coronavirus Investment Forum
01:00pm, Monday, 06'th Jul 2020
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive O
Geode Capital Management LLC Purchases 36,961 Shares of Meredith Co. (NYSE:MDP)
05:01am, Monday, 06'th Jul 2020
Geode Capital Management LLC boosted its stake in shares of Meredith Co. (NYSE:MDP) by 7.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchang
Jane Street Group LLC Decreases Stake in Meredith Co. (NYSE:MDP)
08:25am, Friday, 03'rd Jul 2020
Jane Street Group LLC reduced its position in Meredith Co. (NYSE:MDP) by 15.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC
Invesco Ltd. Has $12.80 Million Stake in Meredith Co. (NYSE:MDP)
06:16am, Friday, 03'rd Jul 2020
Invesco Ltd. decreased its position in Meredith Co. (NYSE:MDP) by 3.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned
Credit Suisse pays $75,000 to comply with infringement notice issued by ASIC - FinanceFeeds
04:44am, Friday, 03'rd Jul 2020
From March 2017 to November 2018, Credit Suisse entered into a number of trades by matching orders on behalf of both its buying and selling clients, and reported these to ASX as “Trades with Price I
ASIC: Credit Suisse Pays US$51.9K Penalty for NXXT Trades | Finance Magnates
02:32am, Friday, 03'rd Jul 2020
ASIC announced that Credit Suisse Equities (Australia) Limited has paid a penalty of $75,000 in order to comply with an infringement notice from the MDP.
